Cell Therapeutics is engaged in the development, acquisition and commercialization of drugs for the treatment of cancer. The company is developing Pixuvri for the treatment of hematologic malignancies and solid tumors; OPAXIO for treating ovarian, brain, esophageal, head and neck cancers; Brostallicin, a synthetic DNA minor groove binding agent; and Bisplantinates for the treatment of various cancers. For more information visit the company’s Web site at www.celltherapeutics.com.

Rodman & Renshaw is a full-service investment bank dedicated to providing corporate finance, strategic advisory, and related services to public and private companies across multiple sectors and regions. Rodman also provides research, sales, and trading services. According to Sagient Research Systems, Rodman has been ranked the #1 Placement Agent in terms of the aggregate number of PIPE and RD financing transactions completed every year since 2005. For more information on Rodman & Renshaw, visit www.rodmanandrenshaw.com.

Let us hear your thoughts below: